Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov
In the last ten years, registered pediatric drug trials have either stayed stable or slightly decreased, often featuring small sample sizes and rarely using age-specific formulations. National regulatory bodies should boost policy support to encourage pediatric drug research and improve trial design quality.
Authors
- Zhaoxin Liu (ORCID: https://orcid.org/0009-0006-9282-6097)
- Hong Shen (ORCID: https://orcid.org/0000-0003-2185-4825)
- Yuejiang Shi
- Siyu Jiang (ORCID: https://orcid.org/0000-0003-0413-1721)
- Yinghong Zhou (ORCID: https://orcid.org/0000-0001-9757-7735)
- Yinghua Lv (ORCID: https://orcid.org/0000-0001-8241-399X)
- Jihan Huang (ORCID: https://orcid.org/0000-0002-2176-737X)
- Xu Ji (ORCID: https://orcid.org/0009-0002-0849-7333)
- Ying Zhang (ORCID: https://orcid.org/0000-0001-9900-7568)
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pediatrics
- Published
- 2025-12-10
- DOI
- https://doi.org/10.3389/fped.2025.1695990
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai University of Traditional Chinese Medicine